Medicare Part D coverage · ibuprofen · RxCUI 197804
ibuprofen 300 MG Oral Tablet
Per the CMS 2026 Part D formulary file, ibuprofen 300 MG Oral Tablet is covered by 11 Medicare Part D plans (0.2% of enrollable products), averaging Tier 1.5, with prior authorization required on 0% of covering formularies.
- 0.2%
- Plan coverage
- 11
- Plans covering
- T1.5
- Avg tier
- 0%
- Prior auth required
What the CMS Formulary Data Shows for ibuprofen 300 MG Oral Tablet
Per the CMS 2026 Part D formulary file, ibuprofen 300 MG Oral Tablet (RxNorm concept RXCUI 197804, generic name ibuprofen) appears on 2 distinct formulary files spanning 11 Medicare Part D plan offerings - 0.2% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 2, with a cross-plan average of Tier 1.5.
Real-world access to ibuprofen 300 MG Oral Tablet depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 3,444,665 Part D beneficiaries filled ibuprofen 300 MG Oral Tablet in 2023, with total plan-and-beneficiary spending of $56,974,758 and an average per-beneficiary annual cost of $16.54. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry ibuprofen 300 MG Oral Tablet today.
Coverage Details
- Formularies covering
- 2
- Plans covering
- 11
- Coverage rate
- 0.2%
- Tier range
- Tier 1 – Tier 2
- Average tier
- Tier 2, Generic
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 3,444,665
- Total spending
- $56,974,758
- Avg per beneficiary
- $16.54
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering ibuprofen 300 MG Oral Tablet
11 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| CareAdvantage (HMO D-SNP) | SAN Mateo Health Commission | T1 | No | $0 | CA |
| Health First Rewards H1099-014 (HMO) | Health First Health Plans | T2 | No | $0 | FL |
| Health First SunSaver H1099-016 (HMO) | Health First Health Plans | T2 | No | $0 | FL |
| Health First Complete Care H1099-023 (HMO) | Health First Health Plans | T2 | No | $0 | FL |
| Health First Emerald Plus H1099-024 (HMO) | Health First Health Plans | T2 | No | $0 | FL |
| Health First Premier Access H1099-025 (HMO-POS) | Health First Health Plans | T2 | No | $0 | FL |
| Health First Emerald Plus H1099-026 (HMO) | Health First Health Plans | T2 | No | $0 | FL |
| Health First Premier Access H1099-027 (HMO-POS) | Health First Health Plans | T2 | No | $0 | FL |
| Health First Emerald Plus H1099-028 (HMO) | Health First Health Plans | T2 | No | $0 | FL |
| Health First Value H1099-006 (HMO) | Health First Health Plans | T2 | No | $15.00 | FL |
| Health First Classic H1099-001 (HMO-POS) | Health First Health Plans | T2 | No | $49.40 | FL |
Frequently Asked Questions
Is ibuprofen 300 MG Oral Tablet covered by Medicare Part D?
Yes, ibuprofen 300 MG Oral Tablet is covered by 11 Medicare Part D plans (0.2% of all Part D formularies).
What tier is ibuprofen 300 MG Oral Tablet on Medicare Part D plans?
ibuprofen 300 MG Oral Tablet averages Tier 1.5 across Part D plans, ranging from Tier 1 to Tier 2.
Does ibuprofen 300 MG Oral Tablet require prior authorization?
0% of Part D formularies require prior authorization for ibuprofen 300 MG Oral Tablet. Step therapy: 0%. Quantity limits: 0%.
How much does Medicare spend on ibuprofen 300 MG Oral Tablet?
In 2023, total Medicare Part D spending on ibuprofen 300 MG Oral Tablet was $56,974,758, covering 3,444,665 beneficiaries. The average spend per beneficiary was $16.54.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- bisoprolol fumarate 2.5 MG / hydrochlorothiazide 6.25 MG Oral Tablet T1.5
- estradiol 0.1 MG/ML Vaginal Cream [Estrace] T1.5
- glycopyrrolate 1.5 MG Oral Tablet T1.5
- topiramate 50 MG Oral Tablet T1.5
- bisoprolol fumarate 10 MG / hydrochlorothiazide 6.25 MG Oral Tablet T1.5
- hydrocortisone 10 MG/ML Topical Cream T1.5
Similar prior-authorization rate
- metronidazole 10 MG/ML Topical Cream [Noritate] 0% PA
- 24 HR minocycline 40 MG Extended Release Oral Capsule [Emrosi] 0% PA
- buspirone hydrochloride 10 MG Oral Capsule [Bucapsol] 0% PA
- diflunisal 375 MG Oral Tablet [Dolobid] 0% PA
- hydrocortisone 1 MG/ML Oral Solution [Khindivi] 0% PA
- indomethacin 50 MG Rectal Suppository [Indocin] 0% PA